title: Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
authors.affiliation: University of Chicago, Section of Transplantation Surgery, IL 60637, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Bruce
authors.forename: K A
authors.initials: KA
authors.lastname: Newell
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
authors.forename: J M
authors.initials: JM
authors.lastname: Millis
authors.forename: J B
authors.initials: JB
authors.lastname: Piper
authors.forename: E
authors.initials: E
authors.lastname: Huss
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016035:Pancreas Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone